Skip to content
Screener

Edgewise Therapeutics, Inc. EWTX Prepaid & Other Current

Prepaid & Other Current at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.22B-22.8%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$105.78M-17.1%
Cytokinetics logo
CytokineticsCYTK
$17.99M-10.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$66.05M+15.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$48.87M+307%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$16.79M+59.5%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$4.73B+245%
Enterprise value$4.7B+253%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:09 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056713
AssetsAs of / March 31, 2026 / (unaudited)As of / December 31, 2025
Current assets
Cash and cash equivalents$33,211$61,148
Marketable securities, available for sale466,351468,961
Prepaid expenses and other assets10,23013,276
Total current assets509,792543,385
Property and equipment, net7,3967,831
Operating lease right-of-use asset1,3341,387
Total assets$518,522$552,603

Item 1. Financial Statements (Unaudited)

FAQ

What is Edgewise Therapeutics, Inc.'s prepaid & other current?
Edgewise Therapeutics, Inc. (EWTX) reported prepaid & other current of $10.23M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Edgewise Therapeutics, Inc.'s prepaid & other current increased by 50.6% year-over-year, from $6.79M to $10.23M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s prepaid & other current has grown at a 40.5% compound annual growth rate (CAGR), from $10.23M to $39.89M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Edgewise Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude